Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) shared a poster depicting positive data amassed over two years from its Phase 2 FAB-C trial evaluating its flagship product Zygel (ZYN002), a patent-protected CBD skin gel, to treat children and adolescents with Fragile X syndrome. The Devon, Pennsylvania-based company said the poster was available at the American Academy of Neurology (AAN) science highlights virtual session. A copy of the poster is also available on the company website. Fragile X is a genetic condition caused by a mutation in the FMR1 gene. The mutation causes the X chromosome to appear constricted, or fragile, under a microscope, hence its name. Patients with Fragile X often have learning disabilities and other cognitive impairments.
Genprex Inc (NASDAQ:GNPX) shares got a boost Tuesday after analysts at Noble Capital Markets reiterated an Outperform rating and $5 price target, writing that its lead drug candidate “has the potential to become an effective add-on therapy for the treatment of non-small cell lung cancer (NSCLC).” The company is preparing an Investigational New Drug application and is planning Phase 1/2 trials for late 2020 of GEN-001 (Oncoprex) in combination with AstraZeneca's Tagrisso or Merck's Keytruda. “In our view, positive results from GEN-001 ongoing programs could potentially act as a positive catalyst for the shares."
PyroGenesis Canada Inc (CVE:PYR) (OTCQB:PYRNF) has increased its stake in partner HPQ Silicon Resources Inc. (CVE:HPQ) (OTCMKTS:URAGF). According to a statement Tuesday, HPQ directors have agreed to settle an outstanding debt for services rendered by PyroGenesis Canada in connection with works relating to leasehold improvements done in the dedicated PUREVAPTM Quartz Reduction Reactor premises within PyroGenesis production plant. The outstanding debt of $395,514 will be settled by issuing 4,394,600 units at a price of $0.09 apiece.
Internet of Things Inc (CVE:ITT) (OTCMKTS:INOTF) said Tuesday that it has been granted interim marketing and sales permission for its newly developed fever-detection system ThermalPass to help battle the spread of coronavirus (COVID-19). The technology provides fast, touch-free scanning of multiple people at entranceways of public buildings and spaces. This include bus and train stations, schools, malls, office buildings, and sports venues. The ThermalPass system is unique compared to other fever detecting devices, as it uses medical-grade sensors, and not cameras.
Ozop Surgical Corp (OTCPK:OZSC) announced that Power Conversion Technologies Inc (PCTI) has shipped an order for equipment to one of its clients — a publicly traded Fortune 500 engineering, procurement, fabrication, construction and maintenance company. The equipment will be used for the client’s research in naval nuclear propulsion technology which the company conducts in conjunction with the US Navy, according to a statement Tuesday. Ozop Surgical said PCTI also received additional follow-on purchase orders expected to ship in the coming months. Ozop Surgical said PCTI, a private company it announced in February it was acquiring, has extensive experience in servicing naval technology-related clients.
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) is presenting two posters on the safety, effectiveness and quality of life data amassed from its Phase 2 BELIEVE study to evaluate its flagship product Zygel (ZYN002), a patent-protected CBD skin gel, to treat children and adolescents with a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies (DEE). In a statement on Tuesday, the Devon, Pennsylvania-based company said the data is being presented at the American Academy of Neurology (AAN) science highlights virtual session. The posters can also be viewed on the Zynerba company website. “BELIEVE data continue to build on the strong safety and tolerability profile of Zygel that we’ve seen across our clinical trial programs, and provide evidence of its anti-seizure activity in children and adolescents suffering from developmental and epileptic encephalopathies, or DEEs,” Chief Medical Officer Joseph M Palumbo said in a statement.
Micron Waste Technologies (CSE:MWM) (OTCQB:MICWF) said Tuesday that its wholly-owned subsidiary Covid Technologies Inc is preparing to start manufacturing face masks to prevent the spread of the coronavirus (COVID-19). The group said Covid Technologies plans to deliver high-quality vapour barrier technology (masks, protective garments) to protect against biological hazards, pathogens, and superbugs The much-needed personal protection equipment (PPE) will be made at Covid Technologies’ facility in Delta, British Columbia.
Allot Ltd (NASDAQ:ALLT) has launched its new BusinessSecure solution to help telecommunications service providers protect their small and medium-sized business (SMB) and enterprise customers from malware, phishing, ransomware, crypto-mining and other cybersecurity threats, while boosting revenue. In a statement on Tuesday, the smart network intelligence solutions company said BusinessSecure is the “newest member” of the Allot Secure family - the world’s largest deployed network-based security service for the mass market with over 23 million paying customers. It includes solutions for a unified experience on devices that are on mobile networks (NetworkSecure), fixed home networks (HomeSecure), public Wi-Fi networks (EndpointSecure), and for IoT devices (IoTSecure).
EuroLife Brands (CSE:EURO) (FSE:3CMA) (OTC PINK:EURPF) is forming a global mushroom education initiative with Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) (FSE:8EC), a new initiative which expands on an agreement between the two firms announced on May 15. The deal formalizes a cloud-based, globally accessible, educational experience for patients, clinics, and academic circles to participate, learn, interact, and create information on the uses, treatments, and applications of mushrooms for health and wellness. The two companies will also create a mushroom portal that will leverage the same technology platform used for its cannabis portal and will include educational modules on a wide range of topics. The platform will also incorporate dynamic and interactive elements to facilitate learning.
Pure Gold Mining Inc (CVE:PGM) (LON:PUR) said it has enough funds to kick off exploration drilling at its Red Lake gold mine development project in Ontario, as it revealed it had raised C$12.3 million from an exercise of share purchase warrants. The firm is currently building the mine - the highest-grade underground project in Canada. The exploration program is earmarked to begin on June 3 and will include drilling in a bid to expand resources in areas targeted for early production, as well as expanding high-grade discoveries at surface and at depth across the 47 square kilometre asset.
Heritage Cannabis Holdings Corp (CSE:CANN) (CNSX:CANN.CN) (OTC:HERTF) hs said it will be launching its own series of formulated extraction products under the brand name Purefarma, which will be sold through its subsidiary Voyage Cannabis Corp. The Purefarma brand will be sold through recreational channels and will feature several products that consumers have previously identified with having potential medical benefits, including cannabidiol (CBD) tinctures and a CBD vape pen made without any carrier oils or added flavors.
Co-Diagnostics Inc (NASDAQ:CODX) announced Tuesday that a paper published in the Journal of Clinical Pathology shows that its coronavirus test kits could detect the SARS-CoV-2 virus in cancer tissue, even before symptoms occur. The paper described a study conducted in Italy of the company’s Logix Smart COVID-19 test kits, which was used to test a tumor removed from a cancer patient who later became symptomatic and was diagnosed with the coronavirus.
Exactus Inc (OTCMKTS:EXDI), the healthcare group which farms and manufactures hemp-derived cannabidiol (CBD) products, said 2019 saw it build the foundation to become an industry leader. "2019 was a transformational year for Exactus as we entered into the hemp market in January,” Emiliano Aloi, Exactus president said in a statement accompanying the firm's results for the year to December 30, 2019. Entering the hemp market early in 2019 meant the group posted revenue for the year of C$345,680 versus zero in 2018, while the net loss was around C$10.2 million from a loss of around C$4.3 million the previous year as expenditure inevitably increased. Exactus said it expects gross margins to improve as it begins using lower-cost inventory from its fall harvest.
Esports Entertainment Group Inc (NASDAQCM:GMBL) has formed a new wholly-owned subsidiary, GMBL New Jersey Inc to commence its strategy of pursuing gambling licenses throughout the US. The Malta-based company said its US operations will be based in New Jersey, where the online gambling company expects to establish facilities and operating personnel. Esports said it expects to make its first licence application with the State of New Jersey in the near future and will provide updates for each anticipated application as they are submitted in each available jurisdiction. The announcement it is establishing a foothold in the US comes as Esports raised $2.75 million in a financing
GlobeX Data Ltd (OTCQB:SWISF) (CSE:SWIS) has signed a letter of intent (LOI) with a conglomerate representing over 2,000 cybersecurity resellers in Mexico, Colombia, Panama, Peru and Guatemala to sell all of its cybersecurity, data recovery and secure communications services, DigitalSafe, PrivaTalk, PrivaTalk Messenger and Custodia. GlobeX noted that the parent company of the conglomerate is based in Madrid, Spain, adding that it is also working on getting the Spanish firm on board for all its 1,000 resellers in Spain.
Great Bear Resources Ltd (CVE:GBR) (OTCQX:GTBDF) has struck a deal with two First Nations groups over exploration in Ontario. The deal with the Wabauskang First Nation (WFN) and Lac Seul First Nation (LSFN) over land within their traditional territories seeks to define the engagement between the parties, the junior explorer said. Great Bear said it has issued 100,000 of its shares to Wabauskang First Nation and Lac Seul First Nation at a deemed price of C$11.55, which is equal to the market price on May 4. The shares are to be divided equally between the two groups.
mCloud Technologies Corp (CVE:MCLD) (OTCQB:MCLDF) revealed first-quarter 2020 revenues of C$6.6 million and a strong jump in full-year 2019 revenues, especially in the fourth quarter, driven by the strength of its AssetCare division. and sees a backlog of further AssetCare implementations to come as coronavirus restrictions ease. The technology solutions group posted 2019 revenues of C$18.3 million, a tenfold rise from 2018's C$1.8 million, with fourth-quarter 2019 revenues coming in at C$10.0 million, more than 60% of which came from AssetCare solutions. The company also noted that around two-thirds, or 63%, of first quarter 2020 revenues resulted from the AssetCare platform, a solution that combines IoT, artificial intelligence and cloud computing to ensure assets operate continuously at peak performance.
Ideanomics Inc (NASDAQ:IDEX) revealed that it's Mobile Energy Global (MEG) division has officially launched the largest auto trading market in Qingdao, China at MEG's Qingdao electric vehicle (EV) hub. The company, which focuses on facilitating the adoption of commercial electric vehicles and developing next-generation financial services and Fintech products, said the MEG Center now hosts a full suite of car dealer services for new energy and used cars with a capacity of 18,000 vehicles on site. The facility also offers a one-stop buying experience that includes financial services and onsite vehicle registration services.
NexTech AR Solutions Corp (CSE:NTAR) (OTCQB:NEXCF) said it has signed a deal to provide its augmented reality (AR) solutions to a global technology company with a $30 billion market cap. The company will supply its client with a brandable ARitize app for technology product demonstrations. Because of the social distancing restrictions imposed by the coronavirus pandemic, the companies are working together to create new AR business use cases, NexTech said. “We are gratified to be adding yet another billion-dollar global leader to our customer base as they have the option of choosing anyone and only choose the best of the best,” CEO Evan Gappelberg said in a statement.
Medallion Resources Ltd (CVE:MDL) (OTCPK:MLLOF) has said its US rare earth elements (REE) supply business strategy has been reinforced by the current coronavirus pandemic. "This is an exciting and pivotal time to take on the role of CEO at Medallion Resources, and I appreciate the opportunity provided by the board," said newly-appointed boss, Mark Saxon in an update about the company's plans. "The momentum in the US for secure domestic REE supply to support industry and defense is now stronger than ever. The Medallion strategy to extract REEs from readily available by-product feedstock, using a proprietary technology, places the company in an early mover position. As a new mine does not need to be built or permitted, Medallion can execute in a relatively short time frame with low capital requirements,” Saxton added.
Australis Capital Inc. (CSE:AUSA) (OTCMKTS:AUSAF) said that, at the request of IIROC, it wishes to confirm that the company's management is unaware of any material change in the group's operations that would account for a recent increase in market activity.
CytoDyn Inc. (OTCQB:CYDY), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, has announced that Nader Pourhassan, its president and chief executive officer, and Jacob Lalezari, chief science officer, will host an investment community conference call on Tuesday, May 26, 2020, at 1.00pm PT / 4.00pm ET to provide a comprehensive update on several recent clinical and regulatory developments. Management will dedicate approximately 30 minutes to address questions from analysts and investors. The dial-In number are - US: 877-407-2986; International: 201-378-4916. A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR calendar and will be archived for 30 days. The webcast can also be accessed via the following link: https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/38441/indexl.html. A replay of the conference call will be available until June 26, 2020, by dialling 877-660-6853 (US) / 201-612-7415 (international) and entering conference identification number 13702767.
Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) has said that Jerome D. Jabbour, its chief executive officer, has been invited to present a company overview during the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 8.00am ET. It added that Jabbour will also host investor meetings during the conference and investors interested in arranging a virtual meeting with the company's management during this conference should contact the conference coordinator. A live webcast of the panel discussion will be available on the IR Calendar page of the Investors section of the company’s website: www.matinasbiopharma.com. A webcast replay will be accessible for 90 days following the live presentation.
Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in sustainable bioprotection and plant health solutions, has announced that its management will present at the June 2020 Virtual Investor Summit on June 9-12, 2020, at 3.55pm Eastern time (12.55pm Pacific time) via a webcast: https://www.webcaster4.com/Webcast/Page/2038/35033. The group said its management will host virtual one-on-one investor meetings throughout the event.
Harvest One Cannabis Inc. (CVE:HVT) (OTCQX:HRVOF) has announced the postponement of the filing its interim consolidated financial statements, accompanying management's discussion and analysis and related CEO and CFO certifications for the three and nine months ended March 31, 2020, due to logistical delays and circumstances caused by the coronavirus (COVID-19) pandemic. The group said it is continuing to work diligently and expeditiously to prepare and finalize its interim filings and estimates they will be filed by June 30, 2020. The company confirmed that since the filing of its last interim consolidated financial statements on March 2, 2020, there have been no material business developments other than those that have already been publicly disclosed.